Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of N91115 in Cystic Fibrosis
NCT02227888Phase 1Completed
- Sponsor
- Nivalis Therapeutics
- Start
- Oct 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cavosonstat in cystic fibrosis (CF), sponsored by Nivalis Therapeutics. Primary endpoint: Pharmacokinetics at 14 days. Started Oct 2014; status: completed.
02
Drugs
cavosonstat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02227888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227888.